201 related articles for article (PubMed ID: 30129004)
1. The Protective Effect of Repeated 1MeTIQ Administration on the Lactacystin-Induced Impairment of Dopamine Release and Decline in TH Level in the Rat Brain.
Wąsik A; Romańska I; Zelek-Molik A; Nalepa I; Antkiewicz-Michaluk L
Neurotox Res; 2018 Oct; 34(3):706-716. PubMed ID: 30129004
[TBL] [Abstract][Full Text] [Related]
2. Multiple Administration of Endogenous Amines TIQ and 1MeTIQ Protects Against a 6-OHDA-Induced Essential Fall of Dopamine Release in the Rat Striatum: In Vivo Microdialysis Study.
Wąsik A; Romańska I; Zelek-Molik A; Antkiewicz-Michaluk L
Neurotox Res; 2018 Apr; 33(3):523-531. PubMed ID: 29076060
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the Effects of Acute and Chronic Administration of Tetrahydroisoquinoline Amines on the In Vivo Dopamine Release: A Microdialysis Study in the Rat Striatum.
Wąsik A; Romańska I; Antkiewicz-Michaluk L
Neurotox Res; 2016 Nov; 30(4):648-657. PubMed ID: 27568335
[TBL] [Abstract][Full Text] [Related]
4. The impact of 1MeTIQ on the dopaminergic system function in the 6-OHDA model of Parkinson's disease.
Wąsik A; Polak D; Romańska I; Michaluk J; Antkiewicz-Michaluk L
Pharmacol Rep; 2016 Dec; 68(6):1205-1213. PubMed ID: 27657483
[TBL] [Abstract][Full Text] [Related]
5. Early increase in dopamine release in the ipsilateral striatum after unilateral intranigral administration of lactacystin produces spontaneous contralateral rotations in rats.
Konieczny J; Lenda T; Czarnecka A
Neuroscience; 2016 Jun; 324():92-106. PubMed ID: 26964686
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective Effect of the Endogenous Amine 1MeTIQ in an Animal Model of Parkinson's Disease.
Wąsik A; Romańska I; Michaluk J; Zelek-Molik A; Nalepa I; Antkiewicz-Michaluk L
Neurotox Res; 2016 Apr; 29(3):351-63. PubMed ID: 26303030
[TBL] [Abstract][Full Text] [Related]
7. Both stereoselective (R)- and (S)-1-Methyl-1,2,3,4-tetrahydroisoquinoline enantiomers protect striatal terminals against rotenone-induced suppression of dopamine release.
Antkiewicz-Michaluk L; Wąsik A; Romańska I; Bojarski A; Michaluk J
Neurotox Res; 2011 Aug; 20(2):134-49. PubMed ID: 21069490
[TBL] [Abstract][Full Text] [Related]
8. Chronic L-DOPA treatment attenuates behavioral and biochemical deficits induced by unilateral lactacystin administration into the rat substantia nigra.
Konieczny J; Czarnecka A; Lenda T; Kamińska K; Lorenc-Koci E
Behav Brain Res; 2014 Mar; 261():79-88. PubMed ID: 24361083
[TBL] [Abstract][Full Text] [Related]
9. 1-Methyl-1,2,3,4-tetrahydroisoquinoline antagonizes a rise in brain dopamine metabolism, glutamate release in frontal cortex and locomotor hyperactivity produced by MK-801 but not the disruptions of prepulse inhibition, and impairment of working memory in rat.
Pietraszek M; Michaluk J; Romańska I; Wasik A; Gołembiowska K; Antkiewicz-Michaluk L
Neurotox Res; 2009 Nov; 16(4):390-407. PubMed ID: 19649683
[TBL] [Abstract][Full Text] [Related]
10. Different effects of intranigral and intrastriatal administration of the proteasome inhibitor lactacystin on typical neurochemical and histological markers of Parkinson's disease in rats.
Lorenc-Koci E; Lenda T; Antkiewicz-Michaluk L; Wardas J; Domin H; Smiałowska M; Konieczny J
Neurochem Int; 2011 Jun; 58(7):839-49. PubMed ID: 21419185
[TBL] [Abstract][Full Text] [Related]
11. Important role of 3-methoxytyramine in the inhibition of cocaine sensitization by 1-methyl-1,2,3,4-tetrahydroisoquinoline: an in vivo microdialysis study.
Wąsik A; Romańska I; Antkiewicz-Michaluk L
Pharmacol Rep; 2010; 62(6):983-97. PubMed ID: 21273655
[TBL] [Abstract][Full Text] [Related]
12. Novel D3 dopamine receptor-preferring agonist D-264: Evidence of neuroprotective property in Parkinson's disease animal models induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and lactacystin.
Li C; Biswas S; Li X; Dutta AK; Le W
J Neurosci Res; 2010 Aug; 88(11):2513-23. PubMed ID: 20623619
[TBL] [Abstract][Full Text] [Related]
13. Pro-cognitive effect of 1MeTIQ on recognition memory in the ketamine model of schizophrenia in rats: the behavioural and neurochemical effects.
Białoń M; Żarnowska M; Antkiewicz-Michaluk L; Wąsik A
Psychopharmacology (Berl); 2020 Jun; 237(6):1577-1593. PubMed ID: 32076746
[TBL] [Abstract][Full Text] [Related]
14. Antidepressant-Like Effect of the Endogenous Neuroprotective Amine, 1MeTIQ in Clonidine-Induced Depression: Behavioral and Neurochemical Studies in Rats.
Antkiewicz-Michaluk L; Romańska I; Wąsik A; Michaluk J
Neurotox Res; 2017 Jul; 32(1):94-106. PubMed ID: 28367606
[TBL] [Abstract][Full Text] [Related]
15. Comparative behavioral and neurochemical studies of R- and S-1-methyl-1,2,3,4-tetrahydroisoquinoline stereoisomers in the rat.
Wąsik A; Romańska I; Michaluk J; Antkiewicz-Michaluk L
Pharmacol Rep; 2012; 64(4):857-69. PubMed ID: 23087137
[TBL] [Abstract][Full Text] [Related]
16. The effect of an endogenous compound 1-methyl-1,2,3,4,-tetrahydroisoquinoline on morphine-induced analgesia, dependence and neurochemical changes in dopamine metabolism in rat brain structures.
Wasik A; Romańska I; Antkiewicz-Michaluk L
J Physiol Pharmacol; 2007 Jun; 58(2):235-52. PubMed ID: 17622694
[TBL] [Abstract][Full Text] [Related]
17. Direct intranigral administration of an ubiquitin proteasome system inhibitor in rat: behavior, positron emission tomography, immunohistochemistry.
Mackey S; Jing Y; Flores J; Dinelle K; Doudet DJ
Exp Neurol; 2013 Sep; 247():19-24. PubMed ID: 23557600
[TBL] [Abstract][Full Text] [Related]
18. Different action on dopamine catabolic pathways of two endogenous 1,2,3,4-tetrahydroisoquinolines with similar antidopaminergic properties.
Antkiewicz-Michaluk L; Michaluk J; Mokrosz M; Romanska I; Lorenc-Koci E; Ohta S; Vetulani J
J Neurochem; 2001 Jul; 78(1):100-8. PubMed ID: 11432977
[TBL] [Abstract][Full Text] [Related]
19. The significance of rotational behavior and sensitivity of striatal dopamine receptors in hemiparkinsonian rats: A comparative study of lactacystin and 6-OHDA.
Konieczny J; Czarnecka A; Lenda T; Kamińska K; Antkiewicz-Michaluk L
Neuroscience; 2017 Jan; 340():308-318. PubMed ID: 27826109
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of 1-methyl-1,2,3,4-tetrahydroisoquinoline against dopaminergic neurodegeneration in the extrapyramidal structures produced by intracerebral injection of rotenone.
Antkiewicz-Michaluk L; Wardas J; Michaluk J; Romaska I; Bojarski A; Vetulani J
Int J Neuropsychopharmacol; 2004 Jun; 7(2):155-63. PubMed ID: 14741061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
